Provided by Tiger Trade Technology Pte. Ltd.

Reliance Global Group, Inc.

3.02
+0.525021.04%
Post-market: 2.99-0.0300-0.99%19:58 EDT
Volume:589.40K
Turnover:1.73M
Market Cap:3.03M
PE:-0.15
High:3.24
Open:2.53
Low:2.42
Close:2.50
52wk High:78.00
52wk Low:1.75
Shares:1.00M
Float Shares:951.89K
Volume Ratio:6.39
T/O Rate:61.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-20.1228
EPS(LYR):-51.2678
ROE:-123.46%
ROA:-33.83%
PB:0.46
PE(LYR):-0.06

Loading ...

Reliance Global Group Positions ENQUANTUM to Help Secure the Post-Quantum Economy Before “Q-Day”

GlobeNewswire
·
Jun 01

Reliance Global Group Provides Update on Enquantum Private 5G Deployment and Smart Infrastructure Initiatives

THOMSON REUTERS
·
May 18

NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM

Reuters
·
May 17

Reliance Global Group Inc trading halted, news pending

TIPRANKS
·
May 16

Reliance Global implements 1-for-40 reverse stock split

TIPRANKS
·
May 14

BRIEF-Reliance Global Group Announces Reverse Stock Split

Reuters
·
May 14

Reliance Global Group announces 1-for-40 reverse stock split to meet Nasdaq bid rule

Reuters
·
May 14

Reliance Global Group Inc - Announces 1-for-40 Reverse Stock Split to Regain Nasdaq Compliance

THOMSON REUTERS
·
May 14

Reliance Global Q1 FY26 net loss narrows to $1.4 million; commission income falls to $3.8 million

Reuters
·
May 08

Press Release: Reliance Global Group Reports First Quarter 2026 Results and Advances Scale51 Strategy Through Targeted Technology and Life Sciences Investments

Dow Jones
·
May 08

Reliance Global Group shareholders approve 14 million-share expansion of equity plan

Reuters
·
May 07

Reliance Global Group schedules first-quarter results conference call, business update

Reuters
·
May 06

BRIEF-Reliance Global Group Inc - Launches Lifesci Global

Reuters
·
May 05

Reliance Global Group Launches LifeSci Global, Its Dedicated Life Sciences Platform, Partnering with Proven Operators Scott Korman and David Turner to Build and Lead the Platform with Innervate Radiopharmaceuticals as the First Platform Investment

GlobeNewswire
·
May 05

Reliance Global invests USD 2 million in Innervate Radiopharmaceuticals via LifeSci Global

Reuters
·
May 04

Press Release: Reliance Global Group Completes Transformative Investment in Late-Stage Radiopharmaceutical Innovator Innervate Through EZRA's Biotech Division

Dow Jones
·
May 04

Reliance Global increases ownership in Enquantum to 29%

TIPRANKS
·
Apr 28

Reliance Global Group raises Enquantum stake to 29% after milestone tranche investment

Reuters
·
Apr 28

Reliance Global Group Inc - Expects to Obtain 51% Controlling Interest in Enquantum Upon Milestone Completion

THOMSON REUTERS
·
Apr 28

Reliance Global Group Increases Ownership in Enquantum to 29% Following Achievement of Defined Technical and Commercial Milestones

GlobeNewswire
·
Apr 28